Back to History Current Version

Promoting mental health for university students in China through mindfulness: A randomized controlled trial across six universities

Last registered on September 08, 2025

Pre-Trial

Trial Information

General Information

Title
Promoting mental health for university students in China through mindfulness: A randomized controlled trial across six universities
RCT ID
AEARCTR-0016685
Initial registration date
September 05, 2025

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
September 08, 2025, 9:27 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
Stanford

Other Primary Investigator(s)

PI Affiliation
Stanford
PI Affiliation
Stanford
PI Affiliation
Stanford
PI Affiliation
Stanford
PI Affiliation
Fudan University
PI Affiliation
Beijing Normal University

Additional Trial Information

Status
In development
Start date
2025-10-13
End date
2029-09-01
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Mindfulness-based programs (MBPs), rooted in contemplative practices, have emerged as promising interventions for promoting mental well-being and resilience. Unfortunately, no large-scale study has assessed the efficacy of MBPs for university students in China, a population with
a high prevalence of mental illness. Building off of a pilot study implemented in spring 2025, the primary goal of this larger-scale study is to evaluate the impact of a mindfulness-based program specifically tailored for university students. We will investigate the effects on depression and anxiety symptoms, as well as stress (perceived and physiological), state and trait mindfulness, emotion regulation, flourishing, and other indicators of wellbeing such as sleep quality and somatic symptoms.
External Link(s)

Registration Citation

Citation
Abbey, Cody et al. 2025. "Promoting mental health for university students in China through mindfulness: A randomized controlled trial across six universities." AEA RCT Registry. September 08. https://doi.org/10.1257/rct.16685-1.0
Experimental Details

Interventions

Intervention(s)
In-person mindfulness instruction:
● The in-person mindfulness instruction will consist of weekly 90-minute group sessions, held in a university classroom over eight consecutive weeks, not including an introductory session prior to the formal start of classes.
● Participants will learn foundational principles related to the role of mindfulness, as well as formal and informal mindfulness practices
● Participants will be asked to commit to completing assigned mindfulness practice independently outside of class throughout the intervention period.

Control group:
● Participants assigned to the control group will receive no other intervention during the program (pure control).
Intervention Start Date
2025-10-16
Intervention End Date
2025-12-26

Primary Outcomes

Primary Outcomes (end points)
1. Depression symptoms (PHQ-9)
2. Anxiety symptoms (GAD-7)
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
1. Physiological stress will be measured using cortisol levels. The cortisol levels will be measured via saliva samples starting one week prior to the intervention, three times on the same day at consistent times. At the end of the intervention, the cortisol levels will be measured one week after the course ends, three times on the same day (at the same times as before the intervention).
2. Perceived stress is measured using the Perceived Stress Scale (PSS), measured at baseline, weekly during the intervention, at endline, and in several follow-ups at three months, six months, and four years after the intervention
3. Emotion regulation will be measured using the Emotion Regulation Questionnaire (ERQ) at baseline, weekly during the intervention, at endline, and in several follow-ups at three months, six months, and four years after the intervention
4. Coping strategies will be measured using the Coping Strategies Scale at baseline and endline
5. Trait mindfulness will be measured using the short-form of the Five Facet Mindfulness Questionnaire (FFMQ-SF) at baseline and endline
6. State mindfulness will be measured using the Multidimensional State Mindfulness Questionnaire (MSMQ) at baseline and endline, and measured weekly during the intervention
7. Loneliness will be measured using the short-form of the 6-item UCLA Loneliness Scale at baseline and endline
8. Attachment style will be measured using the Revised Adult Attachment Scale at baseline and endline
9. Recent stressful events will be measured using the Adolescent Self-Rating Life Events Check list (ASLEC) at baseline and endline, and in several follow-ups at three months, six months, and four years after the intervention
10. Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI) at baseline, at endline, and in several follow-ups at three months, six months, and four years after the intervention
11. Flourishing will be measured using the Flourishing Scale (FS) at at baseline, weekly during the intervention, at endline, and in several follow-ups at three months, six months, and four years after the intervention
12. Life satisfaction will be measured using the Satisfaction with Life Scale (SWLS)
13. Academic performance will be measured using the semester GPA and national English test results at baseline and endline, at endline, and in several follow-ups at three months, six months, and four years after the intervention
14. Lifestyle behaviors will be measured using items asking about the amount and frequency of behaviors such as screen use and exercise at baseline and endline
15. Face will be measured using the CPAI-2 at baseline and endline, and in several follow-ups at three months, six months, and four years after the intervention
16. Somatic symptoms will be measured using the brief version of the Somatic Symptom Scale (SSS), at baseline and endline
17. Perceived benefits and adverse effects and helpfulness of the program will be measured with Likert-type items measured weekly during the intervention
18. Compliance with mindfulness practice will be measured based on self-report length and frequency of practice, measured weekly during the intervention.
19. Acceptability of the intervention will be measured via qualitative interviews and focus groups with students and instructors
20. Self-compassion will be measured using the Self-Compassion Scale, measured at baseline and endline, as well as weekly during the intervention
21. Sense of purpose will be measured using the Meaning of Life Questionnaire, measured at baseline and endline
22. Experiential avoidance will be measured using the Brief Experiential Avoidance Questionnaire at baseline and endline
23. Emotion reactivity and instability will be measured using the RIPOST-Y at baseline, endline, weekly during the intervention, and in several follow-ups at three months, six months, and four years after the intervention
24. Career outcomes will be measured using items asking about post-graduation trajectories four years following the intervention
25. Interpersonal tolerance will be measured using the CPAI-2 at baseline and endline
26. Harmony will be measured using the CPAI-2 at baseline and endline
27. Self vs. social orientation will be measured using the CPAI-2 at baseline and endline
28. Neuroticism will be measured using the Big Five Personality Inventory (brief version), at baseline and endline
29. Openness will be measured using the Big Five Personality Inventory (brief version), at baseline and endline
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
We will conduct a randomized study with 360 undergraduate students recruited from six universities in China. Using the RCT method of impact evaluation, we will be able to ensure that the intervention and control groups have similar characteristics at baseline, which is vital for drawing a causal connection between the intervention and any changes in student outcomes. By assuring the similarity of characteristics (such as sex, baseline mental health, etc.) between the treatment and control groups at baseline, we can confidently attribute any significant differences in outcomes between the control and intervention group to the program.

Experimental Design Details
Not available
Randomization Method
Randomization will be conducted via a statistical software program (Stata 16)
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
N/A
Sample size: planned number of observations
360
Sample size (or number of clusters) by treatment arms
180 students control, 180 students mindfulness intervention
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
0.30 SD
IRB

Institutional Review Boards (IRBs)

IRB Name
Stanford University IRB
IRB Approval Date
2024-12-18
IRB Approval Number
75117